- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating biomarkers in hepatocellular carcinoma
Authors
Keywords
Circulating tumour cells (CTCs), Hepatocellular carcinoma (HCC), Cytokeratin 18 (CK18), Prognostic biomarker, Glypican-3 (GPC3)
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 2, Pages 323-332
Publisher
Springer Nature
Online
2014-06-12
DOI
10.1007/s00280-014-2508-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma
- (2013) Ibrahim Yildiz et al. Clinical Genitourinary Cancer
- Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease
- (2013) Bryan D. Maliken et al. HEPATOLOGY
- Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
- (2013) Kornelius Schulze et al. INTERNATIONAL JOURNAL OF CANCER
- Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
- (2013) Oliver Waidmann et al. JOURNAL OF HEPATOLOGY
- Detection of circulating tumour cells in gastric and hepatocellular carcinoma: A systematic review
- (2013) Ping Gao et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer
- (2012) A Greystoke et al. BRITISH JOURNAL OF CANCER
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum cytokeratin 18 as a biomarker for gastric cancer
- (2012) Katsunobu Oyama et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
- (2012) Yun-Fan Sun et al. HEPATOLOGY
- Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives
- (2012) Yu Zhang et al. SEMINARS IN ONCOLOGY
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
- (2011) L Khoja et al. BRITISH JOURNAL OF CANCER
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour cells in cancer patients: challenges and perspectives
- (2010) Klaus Pantel et al. TRENDS IN MOLECULAR MEDICINE
- Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
- (2009) Jian-Mei Hou et al. AMERICAN JOURNAL OF PATHOLOGY
- Major histocompatibility complex class I-related chains A and B (MIC A/B): A novel role in nonalcoholic steatohepatitis
- (2009) Alisan Kahraman et al. HEPATOLOGY
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
- (2008) T. Ishiguro et al. CANCER RESEARCH
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Biomarker method validation in anticancer drug development
- (2007) J Cummings et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started